• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[食管癌的放射治疗及治疗结果(作者译)]

[Radiation therapy and treatment results in carcinoma of the esophagus (author's transl)].

作者信息

Wieland C, Hymmen U

出版信息

Strahlentherapie. 1977 Nov;153(11):719-25.

PMID:337587
Abstract

Results from radiotherapeutic treatment of 200 patients with malignant tumors of the esophagus are reported. The principal part is represented by squamous cell carcinomas with 88%, followed by adenocarcinomas with 4.5%, by more or less differentiated solid carcinomas with 4%, and small cell carcinomas with 1.5%. Sarcoma was found in three cases, one of them a myosarcoma, another a reticulosarcoma. An ectopic carcinoma of the gastric glands was present in one case. The staging was performed according to the TNM system. A focal dose of 6000 to 6500 rd within 6 or 8 weeks was tried for, using 60Co-gamma-rays. The one-year and five-year survival rates in stage T2N0M0 amounted to 80% and to 17%; no survival was obtained in stage T3N0M0. Out of the total of stage T2-3N0M0 cases 24% obtained one-year survival, and 2% five-year survival. In stages T3N2-3M0 and T3Nx-3M1 after one year 9% and 7% of the patients were alive. The mean survival time of stage T2N0M0 cases was 30.5 months; of T3N0M0, 7.3 months; of T3N1-3M0, 5.2 months; of T3Nx-3M1, 3.8 months. The one-year and five-year survival rates, being related to the irradiation dose administered, amounted to 28% and to 2% after a minimum dose of 5000 rd to the focus. With less than 5000 rd, none of the patients survived two years. The bad results of treatment demand new therapeutic pathways. Short-term pre-irradiation followed by surgical treatment is discussed as well as a combined radiation therapy with cobalt-60 and neutrons or a combined radio-chemotherapy using cytostatics.

摘要

报告了200例食管癌患者放射治疗的结果。主要部分为鳞状细胞癌,占88%,其次是腺癌,占4.5%,低分化或高分化实体癌占4%,小细胞癌占1.5%。发现3例肉瘤,其中1例为平滑肌肉瘤,另1例为网状细胞肉瘤。1例存在胃腺异位癌。根据TNM系统进行分期。使用60钴γ射线,尝试在6或8周内给予瘤灶6000至6500拉德的局部剂量。T2N0M0期的1年和5年生存率分别为80%和17%;T3N0M0期无生存病例。在T2 - 3N0M0期的所有病例中,24%获得1年生存,2%获得5年生存。在T3N2 - 3M0期和T3Nx - 3M1期,1年后分别有9%和7%的患者存活。T2N0M0期病例的平均生存时间为30.5个月;T3N0M0期为7.3个月;T3N1 - 3M0期为5.2个月;T3Nx - 3M1期为3.8个月。与所给予的照射剂量相关的1年和5年生存率,在瘤灶接受最低5000拉德剂量后分别为28%和2%。剂量低于5000拉德时,无患者存活两年。治疗效果不佳需要新的治疗途径。讨论了短期放疗后手术治疗,以及钴 - 60与中子联合放疗或使用细胞抑制剂的联合放化疗。

相似文献

1
[Radiation therapy and treatment results in carcinoma of the esophagus (author's transl)].[食管癌的放射治疗及治疗结果(作者译)]
Strahlentherapie. 1977 Nov;153(11):719-25.
2
[Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].[在标准临床实践中采用同步放疗和化疗根治Ⅲ期和Ⅳ期食管癌的努力]
Radiol Med. 2001 Jul-Aug;102(1-2):72-7.
3
[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].[IV期非小细胞肺癌患者放疗后的生存状况——附287例报告]
Ai Zheng. 2006 Nov;25(11):1419-22.
4
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.上颌窦癌的治疗:1997年与1977年美国癌症联合委员会分期系统的比较
Cancer. 1999 Nov 1;86(9):1700-11.
5
Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.顺铂和依托泊苷联合进行有效放化疗用于治疗局部无法手术及转移性食管癌患者。
Cancer. 1996 Oct 15;78(8):1646-50.
6
Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.对于食管鳞状细胞癌和腺癌,先行强化放化疗,然后进行食管切除术。
Cancer J Sci Am. 1997 May-Jun;3(3):144-52.
7
A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.一项针对局限性食管癌患者的外照射放疗、近距离放疗及同步化疗的I/II期研究(放射治疗肿瘤学组研究9207):最终报告
Cancer. 2000 Mar 1;88(5):988-95.
8
[Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].[食管癌表皮样癌的同步强化放化疗。一项针对122例不可手术患者的II期全国多中心试验(FFCD 8803)的长期结果]
Gastroenterol Clin Biol. 2000 Feb;24(2):201-10.
9
Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?食管癌的新辅助治疗:护理标准还是难以捉摸的神话?
Am Surg. 2001 Oct;67(10):956-65.
10
[The combined radiochemotherapy of inoperable esophageal neoplasms: a feasibility study].[不可切除食管肿瘤的放化疗联合治疗:一项可行性研究]
Radiol Med. 1996 Apr;91(4):456-9.